Developer docs
API playgroundTry for free, no card

Search company profiles

MTIP AG

Full company profile

uuid0000pob

Namestring
MTIP AG
Legal namestring
MTIP AG
Websiteurl
mtip.ch
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBasel, Switzerland
HQ citystring
Basel
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, healthtech investments, growth capital, buyout investments, venture capital
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
  • Open-End Investment Funds525910
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

MTIP charges management fees on its closed-end funds (Fund II) and evergreen fund (EverHealth Fund) based on committed capital under management

mtip.ch
2Carried Interest
TypeSubscription Recurring
Description

Performance-based carried interest from successful fund investments, aligning GP and LP interests in generating attractive risk-adjusted returns

mtip.ch
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Institutional investor capital
ModelOtherBilling cadenceMulti-year contract
Notes

Fund management fees and carried interest structures negotiated with LPs including institutional investors, pension funds, family offices, hospitals, and foundations

mtip.ch
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MTIP AG is a Swiss-based specialist growth and buyout private equity investor focused exclusively on European healthcare technology companies. The firm invests in AI-enabled and software-driven healthcare businesses through both majority and minority structures, deploying up to €30 million in equity per deal as either growth capital or structured solutions. MTIP partners closely with founders and management teams to scale market-leading platforms across 12 European countries, generating returns through management fees and carried interest from its portfolio of closed-end and evergreen funds.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • MTIP Fund II closed at $250M above target of $225M
+3 more records
Product overview1 text field

MTIP AG is a Swiss-based specialist growth and buyout investor focused on European healthcare technology companies. The firm offers two primary investment vehicles: the MTIP EverHealth Fund (an evergreen, semi-liquid structure providing continuous exposure) and MTIP Closed-End Funds (traditional closed-end funds for control-oriented investments). MTIP invests in AI-enabled and software-driven healthcare businesses through majority and minority structures, partnering with founders and management teams to scale market-leading businesses. The firm provides growth capital up to €30 million per investment, targeting profitable, growing healthcare technology companies across European markets.

Product and service2 records
1MTIP EverHealth Fund
CategoryInvestment Product
Description

A semi-liquid, evergreen investment vehicle providing continuous exposure to European healthcare technology through direct investments, follow-on investments in existing portfolio companies, and select secondary opportunities. Designed for institutional investors seeking ongoing healthcare technology exposure.

2MTIP Closed-End Funds
CategoryInvestment Product
Description

Traditional closed-end private equity funds with a focused, control-oriented strategy designed to scale market-leading platforms, drive operational excellence, and generate attractive risk-adjusted returns in European healthcare technology. MTIP Fund II closed at USD $250 million above its $225 million target.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-12-19
Description

Advisory firms supporting MTIP and Peakstone's acquisition of Dossier Solutions. Stifel provided M&A advisory, Selmer legal, KPMG financial/tax, Crosslake technical, and CORDET acquisition financing.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

European venture capital firm with deep healthcare technology investing experience across Germany and broader Europe. Comparable to MTIP as a healthcare-focused European growth investor with similar stage and sector overlap.

TypeBroad incumbent
Description

Swedish-based global private equity firm with a substantial healthcare practice spanning technology, services, and life sciences. A larger incumbent peer that competes with MTIP for mid-to-large European healthcare buyouts.

TypeDirect peer
Description

Dutch-based private equity and venture capital firm exclusively focused on healthcare technology and services in Europe. Directly comparable to MTIP as a specialist healthtech PE investor with both growth and buyout strategies across the Benelux and broader European markets.

TypeRegional player
Description

Belgian-listed European investment firm with a dedicated Health & Care platform. Comparable to MTIP as a European mid-market healthcare specialist, though Gimv's broader scope spans multiple sectors beyond healthtech.

TypeDirect peer
Description

French-based private equity platform with a dedicated healthcare technology practice (formerly Edmond de Rothschild Investment Partners). Comparable to MTIP as a European specialist healthcare growth investor with similar ticket sizes.

TypeDirect peer
Description

European healthcare-focused private equity firm investing in commercial-stage healthtech and medtech companies. A direct peer and co-investor with MTIP in Caresyntax, operating with similar ticket sizes and European focus.

TypeDirect peer
Description

Swiss-based specialist investor in medtech and digital health, with a similar European growth-stage focus to MTIP. Directly comparable as a Geneva-based healthtech specialist serving European growth equity markets.

TypeBroad incumbent
Description

Large European private equity firm with a dedicated healthcare vertical covering healthcare technology, services, and life sciences. A broader incumbent peer that overlaps with MTIP in mid-to-large European healthtech buyouts.

TypeBroad incumbent
Description

Global private equity firm with a dedicated European healthcare buyout practice. Overlaps with MTIP in European healthtech buyouts at the larger end; background of MTIP's Investment Director Marton Kenessey at Carlyle underscores the talent overlap.

TypeDirect peer
Description

UK-based private equity firm with a major focus on enterprise and healthcare software investments across Europe. Directly comparable given the healthcare software concentration and prior background of MTIP's Investment Partner Katrin Vatiska at Hg Capital.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment22 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MTIP AG

Healthcare Private Equitymtip.ch

MTIP AG firmographics

Firmographics
Name
MTIP AG
Legal name
MTIP AG
Website
https://mtip.ch
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where MTIP AG is headquartered

Location

Headquarters

HQ city
Basel
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

MTIP AG business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Management Fees: MTIP charges management fees on its closed-end funds (Fund II) and evergreen fund (EverHealth Fund) based on committed capital under management
  2. Carried Interest: Performance-based carried interest from successful fund investments, aligning GP and LP interests in generating attractive risk-adjusted returns

Pricing tiers

ModelBillingPrice
OtherMulti-year contractInstitutional investor capital

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

MTIP AG product offering

Product offering

Core offering

MTIP AG is a Swiss-based specialist growth and buyout private equity investor focused exclusively on European healthcare technology companies. The firm invests in AI-enabled and software-driven healthcare businesses through both majority and minority structures, deploying up to €30 million in equity per deal as either growth capital or structured solutions. MTIP partners closely with founders and management teams to scale market-leading platforms across 12 European countries, generating returns through management fees and carried interest from its portfolio of closed-end and evergreen funds.

Product overview

MTIP AG is a Swiss-based specialist growth and buyout investor focused on European healthcare technology companies. The firm offers two primary investment vehicles: the MTIP EverHealth Fund (an evergreen, semi-liquid structure providing continuous exposure) and MTIP Closed-End Funds (traditional closed-end funds for control-oriented investments). MTIP invests in AI-enabled and software-driven healthcare businesses through majority and minority structures, partnering with founders and management teams to scale market-leading businesses. The firm provides growth capital up to €30 million per investment, targeting profitable, growing healthcare technology companies across European markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • MTIP EverHealth Fund A semi-liquid, evergreen investment vehicle providing continuous exposure to European healthcare technology through direct investments, follow-on investments in existing portfolio companies, and select secondary opportunities. Designed for institutional investors seeking ongoing healthcare technology exposure.
  • MTIP Closed-End Funds Traditional closed-end private equity funds with a focused, control-oriented strategy designed to scale market-leading platforms, drive operational excellence, and generate attractive risk-adjusted returns in European healthcare technology. MTIP Fund II closed at USD $250 million above its $225 million target.

Quantifiable outcome

  • MTIP Fund II closed at $250M above target of $225M
  • +3 more outcomes

Companies that use MTIP AG

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

MTIP AG technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MTIP AG partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Stifel, Selmer, KPMG, Crosslake, CORDETminorImplementation/ SI/ Consulting Partner · 19 December 2024Advisory firms supporting MTIP and Peakstone's acquisition of Dossier Solutions. Stifel provided M&A advisory, Selmer legal, KPMG financial/tax, Crosslake technical, and CORDET acquisition financing.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

MTIP AG competitors and assessment

Company assessment

Direct peers

  • Wellington Partners: European venture capital firm with deep healthcare technology investing experience across Germany and broader Europe. Comparable to MTIP as a healthcare-focused European growth investor with similar stage and sector overlap.
  • Gilde Healthcare: Dutch-based private equity and venture capital firm exclusively focused on healthcare technology and services in Europe. Directly comparable to MTIP as a specialist healthtech PE investor with both growth and buyout strategies across the Benelux and broader European markets.
  • Andera Partners: French-based private equity platform with a dedicated healthcare technology practice (formerly Edmond de Rothschild Investment Partners). Comparable to MTIP as a European specialist healthcare growth investor with similar ticket sizes.
  • Lauxera Capital Partners: European healthcare-focused private equity firm investing in commercial-stage healthtech and medtech companies. A direct peer and co-investor with MTIP in Caresyntax, operating with similar ticket sizes and European focus.
  • Endeavour Vision: Swiss-based specialist investor in medtech and digital health, with a similar European growth-stage focus to MTIP. Directly comparable as a Geneva-based healthtech specialist serving European growth equity markets.
  • Hg Capital: UK-based private equity firm with a major focus on enterprise and healthcare software investments across Europe. Directly comparable given the healthcare software concentration and prior background of MTIP's Investment Partner Katrin Vatiska at Hg Capital.

Broad incumbents

  • EQT (Healthcare): Swedish-based global private equity firm with a substantial healthcare practice spanning technology, services, and life sciences. A larger incumbent peer that competes with MTIP for mid-to-large European healthcare buyouts.
  • Nordic Capital: Large European private equity firm with a dedicated healthcare vertical covering healthcare technology, services, and life sciences. A broader incumbent peer that overlaps with MTIP in mid-to-large European healthtech buyouts.
  • Carlyle (Healthcare): Global private equity firm with a dedicated European healthcare buyout practice. Overlaps with MTIP in European healthtech buyouts at the larger end; background of MTIP's Investment Director Marton Kenessey at Carlyle underscores the talent overlap.

Regional players

  • Gimv: Belgian-listed European investment firm with a dedicated Health & Care platform. Comparable to MTIP as a European mid-market healthcare specialist, though Gimv's broader scope spans multiple sectors beyond healthtech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

MTIP AG social profiles

Digital presence

MTIP AG compliance and trust

Trust signal

Compliance2 records

MTIP AG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MTIP AG leadership team

Management profile

Number of profiles

Profiles14 records

MTIP AG funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MTIP AG M&A and investment

M&A and investment

M&A1 record

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MTIP AG

What does MTIP AG do?

MTIP AG is a Swiss-based specialist growth and buyout private equity investor focused exclusively on European healthcare technology companies. The firm invests in AI-enabled and software-driven healthcare businesses through both majority and minority structures, deploying up to €30 million in equity per deal as either growth capital or structured solutions. MTIP partners closely with founders and management teams to scale market-leading platforms across 12 European countries, generating returns through management fees and carried interest from its portfolio of closed-end and evergreen funds.

Is MTIP AG a public or private company?

MTIP AG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MTIP AG founded?

MTIP AG was founded in 2014. It employs 11 to 50 people.

Where is MTIP AG based?

MTIP AG is headquartered in Basel, Switzerland, in the Europe region.

How does MTIP AG make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are MTIP AG's main competitors?

Direct peers on record are Wellington Partners, Gilde Healthcare, Andera Partners, Lauxera Capital Partners, Endeavour Vision and Hg Capital. Broad incumbents are EQT (Healthcare), Nordic Capital and Carlyle (Healthcare). Gimv is listed as a regional player.

Does MTIP AG have an API?

No public API is recorded for MTIP AG.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chMTIP launches evergreen fund for European healthcare technologyMTIP launched the EverHealth Fund, an evergreen private equity strategy for European healthcare technology, structured as a Luxembourg-domiciled ELTIF. The fund offers EUR and CHF share classes with quarterly subscriptions and redemptions, and is now open for subscriptions.HIT ConsultantM&A: MTIP Acquires Majority Stake in Dossier SolutionsMTIP acquired a majority stake in Dossier Solutions, a healthcare competency management SaaS provider. The deal aims to accelerate US market growth and expand into Germany and Singapore. Dossier plans to expand into new markets, including Germany and Singapore.InvestorsinhealthcareUK: Hexarad raises €13m in growth round led by MTIPHexarad has raised €13 million (approximately US$14 million) in a growth funding round led by MTIP, which marks MTIP's ninth platform investment. Existing shareholders, including the private equity firm Foresight, also reinvested in this round. This funding is aimed at supporting Hexarad's end-to-end radiology solutions.Dealroom.coDigital Therapeutics startups report - beyond the pillDealroom, in partnership with Inkef, MTIP and Speedinvest, published a report on digital therapeutics, software-based medical interventions tested and prescribed like traditional drugs. Global VC funding rose 4x since 2017 to $1.2B year-to-date in 2022, while combined enterprise value of DTx startups reached $31B. Europe's early-stage investment grew 9x since 2016, versus 3.6x in the US.Funding EarlyDigital Therapeutics: Investment and Industry OverviewA report co-produced with Dealroom.co, MTIP and Inkef finds European digital therapeutics VC investment reached $645 million between 2020 and 2022, a ninefold rise from 2016, with corporate investment at $329 million in 2022. The authors cite 394 interventional studies since 2010, 88% filed in the last five years, and note reimbursement barriers, including Germany's DiGA model.Business InsiderApricity wants to help patients maximize their chances of getting pregnant. Check out the 19-slide pitch deck it used to raise $17 million.Apricity, a UK fertility startup, raised $17 million in fresh funds led by Swiss investor MTIP. The company offers digital and in-person fertility services, including home ultrasounds and AI-driven treatment selection. It plans to expand in Spain, Germany, and Italy with the new capital.BusinessCloudVirtual fertility clinic Apricity to expand around EuropeApricity, a virtual fertility clinic, raised about £15 million in a Series B round led by MTIP with participation from Iris Ventures. The funds will support UK growth, European expansion, and adding ultrasound scans to at-home services. The company plans to launch in Spain before year-end, followed by Germany and Italy.BusinessCloudVirtual fertility clinic Apricity to expand around EuropeApricity, a virtual fertility clinic, raised about £15 million in a Series B round led by MTIP, with participation from Iris Ventures. The funds will support UK growth, European expansion, and adding ultrasound scans to at-home services. The company plans to launch in Spain before year-end, followed by Germany and Italy.Silicon CanalsUK-based virtual fertility clinic Apricity raises €17M to expand at-home services in EuropeLondon-based virtual fertility clinic Apricity announced on Monday a €17M Series B round led by Swiss healthtech investor MTIP, with participation from Barcelona-based Iris Ventures. Founder Caroline Noublanche said proceeds will accelerate UK growth, expand to Spain before year-end, then Germany and Italy, and add at-home ultrasound scans. The company claims a 46 per cent success rate per cycle.